Arto Linnervuo
Directeur/Membre du Conseil chez TILT Biotherapeutics Oy
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Akseli Hemminki | M | - |
TILT Biotherapeutics Oy
 TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | 11 ans |
| Tuija Päivi Keinonen | M | 61 |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | - |
| Jyrki Lauri Liljeroos | M | 69 |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | - |
| Aino Kalervo | F | - |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | - |
| Timo Mika Juhani Ahopelto | M | 49 |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | 10 ans |
| Pekka Allan Antero Mattila | M | 65 |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | 4 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Finlande | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Arto Linnervuo
- Réseau Personnel
